Articles

RIVN stock is in focus, as Rivian will report Q3 earnings on Nov. 9. Analysts expect revenue of $551.57 million, up 55,057% YOY. More

APRN stock has multiple reasons to fall today, including disappointing quarterly results and a holdup in expected funding for Blue Apron. More

Although most investors should stay away from extreme speculation, these best nano-cap stocks to buy are surprisingly stout. More

IAA (IAA) stock is moving on Monday thanks to a massive $7.3 billion acquisition deal with Ritchie Bros Auctioneers (RBA). More

Upon closer inspection, Friday's jobs report indicates that a Fed pivot is very close and that the time to buy stocks is right now. More

Verve Therapeutics (VERV) stock is taking a beating on Monday following bad news from the U.S. Food and Drug Administration (FDA). More

One press release with numerous positive catalysts is prompting some VTRS stock traders to load up on the shares today. More

Subscriber Sign in